Wave Life Sciences' alpha-1 antitrypsin deficiency candidate WVE-006 succeeded in the first-ever clinical demonstration of ...

Wave Life Sciences' stock soars on positive initial data showing the first-ever therapeutic RNA editing in humans in the ...

Wave Life Sciences has taken a step toward validating a new modality, becoming the first group to report therapeutic RNA ...

Wave Life Sciences' WVE-006 demonstrates first-ever RNA editing in humans for alpha-1 antitrypsin deficiency, showing ...

Krystal Biotech is gearing up for a very important Q4 of 2024, because it is gearing up to report data from two different ...

Wave claims this is the first clinical data with a therapeutic RNA-editing drug in humans, an achievement that boosted its ...

In a report released today, Andrew Fein from H.C. Wainwright maintained a Buy rating on Wave Life Sciences (WVE – Research Report), with ...

The gene mutation that causes cyclic neutropenia is called the ELANE gene. This gene is responsible for providing instructions to your cells on how to make a protein called neutrophil elastase. This ...

Role of the RAAS in the Pathophysiology of Heart Failure ACE inhibitors have no effect on angiotensin II formed by alternate pathways. In contrast, ARBs would be expected to inhibit the biologic ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

Correspondence to Feng Xu, Department of Neurosurgery, Huashan Hospital, Shanghai Medical College, Fudan University, No 12 Wulumuqi Zhong Road, Shanghai 200040, China; fengxu.dr{at}gmail.com ...